Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis oil in untreatable advanced hepatocellular carcinoma
NL-OMON59778Phase 2Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol, dronabinol in hepatocellular carcinoma (HCC), sponsored by University Medical Center Groningen. Started Oct 2024; status: recruiting.
02
Drugs
cannabidioldronabinol
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NL-OMON59778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59778.